Researchers consolidate the diverse nutritional and medicinal benefits of seaweeds, touting their potential in food, nutraceuticals, and pharmaceuticals. The study also highlights challenges and opportunities in industrial applications, calling for more research to optimize extraction and refinement processes.
Biosyngen receives FDA approval to start Phase I trial for TCR therapy – Pharmaceutical Technology
Biosygen also has two other T-cell therapies in Phase I/II clinical development. Image Credit: Juan Gaertner / Shutterstock. Biosyngen received an all-clear from the US
September 11, 2023